Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Ibodutant (MEN 15596)
print preview
bookmark
share with colleague
General Information
Company
Menarini Group
Description
Non-peptide, selective antagonist of the tachykinin neurokinin 2 (NK2) receptor (TACR2)
Molecular Target
Neurokinin 2 (NK2) receptor (TACR2)
Mechanism of Action
Latest Stage of Development
Phase II
Indication
Irritable bowel syndrome
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information